PDF(Pubmed)
Abstract：
UNASSIGNED: Pharmacopuncture therapy has been used in the conservative treatment of rotator cuff disease adjuvant to acupuncture treatment. Despite the increasing utilization of pharmacopuncture therapy, there is still a lack of high-quality research to support its effectiveness. This pilot study aimed to assess the feasibility of pharmacopuncture therapy adjuvant to acupuncture treatment for rotator cuff disease.
UNASSIGNED: This was a parallel-grouped, pragmatic randomized controlled, pilot study. Forty patients were randomly allocated to either the experimental or the control group. All patients received acupuncture treatment for four weeks, and pharmacopuncture was additionally administered to the experimental group. After eight treatments were delivered over four weeks, follow-up assessments were performed. The primary outcome was the mean change in the visual analog scale (VAS) score for shoulder pain from baseline to visit 8. Secondary outcomes included shoulder pain and disability index (SPADI) at visits 4, 8, and 9, shoulder range of motion (ROM) at visits 4, 8, and 9, EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) at visits 8 and 9, patient global impression of change (PGIC) at visits 8 and 9, and mean rescue medication consumption at visits 8 and 9.
UNASSIGNED: Both groups showed that each treatment effectively improved rotator cuff disease in most assessments. Particularly, the group that received acupuncture plus pharmacopuncture required fewer rescue medications than the group that received acupuncture alone. However, there was little statistically significant difference between the two groups. There were no serious adverse events experienced by patients in this study.
UNASSIGNED: Although there was little statistical difference between the two groups, the combination of acupuncture and pharmacopuncture for rotator cuff disease was associated with a reduction in the rescue medicine dosage compared with acupuncture alone. Also, it confirmed the safety of pharmacopuncture therapy. This pilot study would help design future research on the effectiveness of pharmacopuncture in rotator cuff disease.
UNASSIGNED: This was a parallel-grouped, pragmatic randomized controlled, pilot study. Forty patients were randomly allocated to either the experimental or the control group. All patients received acupuncture treatment for four weeks, and pharmacopuncture was additionally administered to the experimental group. After eight treatments were delivered over four weeks, follow-up assessments were performed. The primary outcome was the mean change in the visual analog scale (VAS) score for shoulder pain from baseline to visit 8. Secondary outcomes included shoulder pain and disability index (SPADI) at visits 4, 8, and 9, shoulder range of motion (ROM) at visits 4, 8, and 9, EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L) at visits 8 and 9, patient global impression of change (PGIC) at visits 8 and 9, and mean rescue medication consumption at visits 8 and 9.
UNASSIGNED: Both groups showed that each treatment effectively improved rotator cuff disease in most assessments. Particularly, the group that received acupuncture plus pharmacopuncture required fewer rescue medications than the group that received acupuncture alone. However, there was little statistically significant difference between the two groups. There were no serious adverse events experienced by patients in this study.
UNASSIGNED: Although there was little statistical difference between the two groups, the combination of acupuncture and pharmacopuncture for rotator cuff disease was associated with a reduction in the rescue medicine dosage compared with acupuncture alone. Also, it confirmed the safety of pharmacopuncture therapy. This pilot study would help design future research on the effectiveness of pharmacopuncture in rotator cuff disease.
摘要：
■药物穿刺疗法已用于肩袖疾病的保守治疗，辅助针灸治疗。尽管越来越多地使用药物穿刺疗法，仍然缺乏高质量的研究来支持其有效性。这项初步研究旨在评估药物穿刺疗法辅助针灸治疗肩袖疾病的可行性。
■这是一个平行分组，语用随机对照，试点研究。40名患者被随机分配到实验组或对照组。所有患者均接受针灸治疗4周,和药物穿刺术额外给予实验组。在四周内进行了八次治疗后，进行随访评估.主要结果是从基线到第8次就诊的肩痛视觉模拟量表（VAS）评分的平均变化。次要结果包括第4、8和9次就诊时的肩痛和残疾指数（SPADI），第4、8和9次就诊时的肩关节活动范围（ROM），第8和9次就诊时的EuroQol5维5级问卷（EQ-5D-5L），第8和9次就诊时的患者总体变化印象（PGIC）以及第8和9次就诊时的平均救援药物消耗量。
■两组均显示，在大多数评估中，每种治疗均有效改善了肩袖疾病。特别是,与单独接受针灸治疗的组相比,接受针灸加药物治疗的组需要更少的救护药物.然而,两组间差异无统计学意义。在这项研究中，患者没有经历严重的不良事件。
■尽管两组之间几乎没有统计学差异，与单纯针灸治疗相比,针灸和药物穿刺联合治疗肩袖疾病与抢救药物剂量减少有关.此外，它证实了药物穿刺疗法的安全性。这项初步研究将有助于设计有关药物穿刺在肩袖疾病中的有效性的未来研究。
■这是一个平行分组，语用随机对照，试点研究。40名患者被随机分配到实验组或对照组。所有患者均接受针灸治疗4周,和药物穿刺术额外给予实验组。在四周内进行了八次治疗后，进行随访评估.主要结果是从基线到第8次就诊的肩痛视觉模拟量表（VAS）评分的平均变化。次要结果包括第4、8和9次就诊时的肩痛和残疾指数（SPADI），第4、8和9次就诊时的肩关节活动范围（ROM），第8和9次就诊时的EuroQol5维5级问卷（EQ-5D-5L），第8和9次就诊时的患者总体变化印象（PGIC）以及第8和9次就诊时的平均救援药物消耗量。
■两组均显示，在大多数评估中，每种治疗均有效改善了肩袖疾病。特别是,与单独接受针灸治疗的组相比,接受针灸加药物治疗的组需要更少的救护药物.然而,两组间差异无统计学意义。在这项研究中，患者没有经历严重的不良事件。
■尽管两组之间几乎没有统计学差异，与单纯针灸治疗相比,针灸和药物穿刺联合治疗肩袖疾病与抢救药物剂量减少有关.此外，它证实了药物穿刺疗法的安全性。这项初步研究将有助于设计有关药物穿刺在肩袖疾病中的有效性的未来研究。
